Press

Healthtech Veteran Steve Schwartz joins Freespira Board

Former Livongo, 23andMe, Allscripts, Healthways and LabCorp leader brings unique expertise to digital therapeutic company PR Newswire | March 16th,…

Freespira’s Digital Therapeutic Now Available to Help Adolescents With Panic Attacks, Panic Disorder and PTSD

PR Newswire | Mar 2, 2021 Breakthrough medication-free treatment brings new hope to adolescents with mental health challenges KIRKLAND,…

Children’s Community Health Plan is first in Wisconsin to offer new digital therapeutic treatment for panic attacks, panic disorder, and PTSD

CCHP | Feb 10, 2021 KIRKLAND, Wash. and MILWAUKEE, Feb. 10, 2021 /PRNewswire/ — Children’s Community Health Plan (CCHP) has partnered with Freespira, Inc., the maker…

Highmark Health Expands Access to Freespira’s Digital Therapeutic Treatment for Panic Attacks, Panic Disorder and PTSD

One of the nation’s largest health plans increases access to Freespira and adds telehealth coaching to its commercial beneficiaries in…

IBH Announces Breakthrough Programs for Panic Attacks and PTSD in Partnership with Freespira

IBH | December 15, 2020 By Nicole Kreider IRVINE, Calif. (December 15, 2020) – IBH Population Health Solutions (Integrated Behavioral Health, Inc.),…

Freespira Finalizes $10 Million Financing to Support Commercialization of Digital Therapeutic for Treatment of Panic Disorder and PTSD

Freespira, Inc. is the new name of Palo Alto Health Sciences KIRKLAND, WA, December 8, 2020 – Freespira, Inc., maker…

Palo Alto Health Sciences Appoints Dean Sawyer as President and Chief Executive Officer

PRNewswire | December 17, 2019 KIRKLAND, Wash., Dec. 17, 2019 /PRNewswire/ — Palo Alto Health Sciences, Inc. (PAHS) announced today that it appointed Dean…

Palo Alto Health Sciences Appoints Joseph Perekupka as Chief Commercial Officer

PRNewswire | September 25, 2019 KIRKLAND, Wash., Sept. 25, 2019 /PRNewswire/ — Palo Alto Health Sciences, Inc. (PAHS), whose product Freespira® is…

Palo Alto Health Sciences Obtains FDA-Clearance for Freespira in Treating Post-Traumatic Stress Disorder

PRNewswire | December 18, 2018 KIRKLAND, Wash., Dec. 18, 2018 /PRNewswire/ — Palo Alto Health Sciences, Inc. (PAHS) announced today that its flagship…